PBX1
(Pre-B-Cell Leukemia Homeobox Protein 1 (PBX1))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
Produktmerkmale
This is a synthetic peptide designed for use in combination with anti-PBX1 antibody (Catalog #: ARP30948_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
PBX1
Reaktivität: Human, Maus, Ratte
Wirt: Synthetic
BP, BI
Applikationshinweise
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
PBX1
(Pre-B-Cell Leukemia Homeobox Protein 1 (PBX1))
Hintergrund
PBX1 binds the sequence 5'-ATCAATCAA-3'. It acts as a transcriptional activator of PF4 in complex with MEIS1. It may be converted into a potent transcriptional activator by the (1,19) translocation. It also may have a role in steroidogenesis and, subsequently, sexual development and differentiation.
Alias Symbols: DKFZp686B09108, MGC126627
Protein Interaction Partner: PAX6,HOXA10,HOXA5,HOXA9,HOXB1,HOXB8,HOXD10,HOXD4,MEIS1,MYH10,NR3C1,PAX6,PBX2,PKNOX1,SMARCD3,HOXA9,HOXB1,HOXB7,HOXB8,HOXD4,HOXD9,MEIS1,MYH10,MYOD1,Myh10,NR3C1,PKNOX1